首页> The Lancet. Infectious diseases> Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.

导出 OA

翻译打印收藏纠错

第一作者： Betty,Mwesigwa

第一单位： Makerere University Walter Reed Project, Kampala, Uganda.

作者： Betty,Mwesigwa ^[1] ; Katherine V,Houser ^[2] ; Amelia R,Hofstetter ^[3] ; Ana M,Ortega-Villa ^[4] ; Prossy,Naluyima ^[1] ; Francis,Kiweewa ^[1] ; Immaculate,Nakabuye ^[1] ; Galina V,Yamshchikov ^[3] ; Charla,Andrews ^[3] ; Mark,O'Callahan ^[3] ; Larisa,Strom ^[3] ; Steven,Schech ^[5] ; Leigh,Anne Eller ^[5] ; Erica L,Sondergaard ^[5] ; Paul T,Scott ^[6] ; Mihret F,Amare ^[5] ; Kayvon,Modjarrad ^[6] ; Amir,Wamala ^[1] ; Allan,Tindikahwa ^[1] ; Ezra,Musingye ^[1] ; Jauhara,Nanyondo ^[1] ; Martin R,Gaudinski ^[3] ; Ingelise J,Gordon ^[3] ; LaSonji A,Holman ^[3] ; Jamie G,Saunders ^[3] ; Pamela J M,Costner ^[3] ; Floreliz H,Mendoza ^[3] ; Myra,Happe ^[3] ; Patricia,Morgan ^[3] ; Sarah H,Plummer ^[3] ; Somia P,Hickman ^[3] ; Sandra,Vazquez ^[3] ; Tamar,Murray ^[3] ; Jamilet,Cordon ^[3] ; Caitlyn N M,Dulan ^[3] ; Ruth,Hunegnaw ^[3] ; Manjula,Basappa ^[3] ; Marcelino,Padilla ^[3] ; Suprabhath R,Gajjala ^[3] ; Phillip A,Swanson ^[3] ; Bob C,Lin ^[3] ; Emily E,Coates ^[3] ; Jason G,Gall ^[3] ; Adrian B,McDermott ^[3] ; Richard A,Koup ^[3] ; John R,Mascola ^[3] ; Aurélie,Ploquin ^[3] ; Nancy J,Sullivan ^[3] ; Hannah,Kibuuka ^[1] ; Julie A,Ake ^[6] ; Julie E,Ledgerwood ^[3] ; RV 508 Study Team

作者单位： Makerere University Walter Reed Project, Kampala, Uganda. ^[1] Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: katherine.houser@nih.gov. ^[2] Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. ^[3] Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. ^[4] Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA. ^[5] Walter Reed Army Institute of Research, Silver Spring, MD, USA. ^[6]